Access in the United States depends on regulatory status, clinical availability, insurance coverage, and the prescribed indication
Insights from Personify Health's Chief Medical Officer With obesity rates and healthcare costs continuing to rise, GLP-1 medications like Ozempic and Wegovy have captured employers' attention, promising significant weight loss and healthcare savings
It doesn't need to fall back on compounded versions that might not be as safe or effective as brand-name drugs
People lose muscle and can potentially lose bone, which is why working with professionals is so important
Keep Learning DOCS Education offers continuing education on SUD in clinical practice
For the complete Medicaid breakdown across all 50 states, see Medicaid GLP-1 coverage by state